Recognition of bacterial endotoxin in the lungs

American Journal of Respiratory Cell and Molecular Biology

Volumn 23, Issue 2, 2000, Pages 128-132

  Martin, Thomas R ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0033836203     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.23.2.f189     Document Type: Review

References (53)

1. 1. Medzhitov, R., and C. A. J. Janeway. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 91:295-298.
2. 2. Sastry, K. and R. A. Ezekowitz. 1993. Collectins: pattern recognition molecules involved in first line host defense. Curr. Opin. Immunol. 5:59-66.
3. 3. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516.
4. 4. Krieger, M. 1997. The other side of scavenger receptors: pattern recognition for host defense. Curr. Opin. Lipidol. 8:275-280.
5. 5. Fraser, I. P., H. Koziel, and R. A. Ezekowitz. 1998. The serum mannose-binding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity. Semin. Immunol. 10:363-372.
6. 6. Marasco, W. A., S. H. Phan, H. Krutzsch, H. J. Showell, D. E. Feltner, R. Nairn, E. L. Becker, and P. A. Ward. 1984. Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259:5430-5439.
7. 7. Ye, R. D., S. L. Cavanagh, O. Quehenberger, E. R. Prossnitz, and C. G. Cochrane. 1992. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184:582-589.
8. 8. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1986. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J. Exp. Med. 164:777-793.
9. 9. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431.
10. 10. Wurfel, M. M. and S. D. Wright. 1997. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. J. Immunol. 158:3925-3934.
11. 11. Wurfel, M. M., S. T. Kunitake, H. Lichenstein, J. P. Kane, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180:1025-1035.
12. 12. Ulevitch, R. J., A. R. Johnston, and D. B. Weinstein. 1981. New function for high density lipoproteins: isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J. Clin. Invest. 67:827-837.
13. 13. Baumberger, C., R. J. Ulevitch, and J. M. Dayer. 1991. Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein. Pathobiology 59:378-383.
14. 14. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
15. 15. Pugin, J., C.-C. Shurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744-2748.
16. 16. Wurfel, M. M., E. Hailman, and S. D. Wright. 1995. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181:1743-1754.
17. 17. Jack, R. S., X. Fan, M. Bernheiden, G. Rune, M. Ehlers, A. Weber, G. Kirsch, R. Mentel, B. Furll, M. Freudenberg, et al. 1997. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature (Lond.) 389:742-745.
18. 18. Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, and S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4:407-414.
19. 19. Lee, J.-D., V. Kravchenko, T. N. Kirkland, J. Han, N. Mackman, A. Moriarty, D. Leturcq, P. S. Tobias, and P. S. Ulevitch. 1993. Glycosylphosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc. Natl. Acad. Sci. USA 90:9930-9934.
20. 20. Anderson, K. V., G. Jurgens, and C. Nusslein-Volhard. 1985. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 42:779-789.
21. 21. Lemaitre, B., E. Nicolas, L. Michaut, J. M. Reichhart, and J. A. Hoffmann. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-983.
22. 22. Belvin, M. P. and K. V. Anderson. 1996. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu. Rev. Cell Dev. Biol. 12:393-416.
23. 23. Medzhitov, R., P. Preston-Hurlburt, and C. A. J. Janeway. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (Lond.) 388:394-397.
24. 24. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Suva, C. Galanos, et al. 1998. Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: mutations in Tlr4 Gene. Science 282:2085-2088.
25. 25. Schwartz, D. A. 2000. Humans with mutation in the Tlr-4 receptor are hyporesponsive to bacterial lipopolysaccharide. Nature Genetics (In press)
26. 26. Rock, F. L., G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588-593.
27. 27. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, and P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature (Lond.) 395:284-288.
28. 28. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature (Lond.) 401:811-815.
29. 29. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. J. Fenton, M. Oikawa, N. Qureshi, B. Monks, et al. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest 105:497-504.
30. 30. Muzio, M., D. Bosisio, N. Polentarutti, G. D'Amico, A. Stoppacciaro, R. Mancinelli, C. van't Veer, G. Penton-Rol, L. P. Ruco, P. Allavena, et al. 2000. Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells. J. Immunol. 164:5998-6004.
31. 31. Muzio, M., N. Polentarutti, D. Bosisio, M. K. Prahladan, and A. Mantovani. 2000. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J. Leukoc. Biol. 67:450-456.
32. 32. Martin, T. R., J. C. Mathison, P. S. Tobias, D. J. Leturcq, A. M. Moriarty, R. J. Maunder, and R. J. Ulevitch. 1992. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipolysaccharide: implications for cytokine production in normal and injured lungs. J. Clin. Invest. 90:2209-2219.
33. 33. Martin, T. R., G. D. Rubenfeld, J. T. Ruzinski, R. B. Goodman, K. P. Steinberg, D. J. Leturcq, A. M. Moriarty, G. Raghu, R. P. Baughman, and L. D. Hudson. 1997. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155: 937-944.
34. 34. Dubin, W., T. R. Martin, P. Swoveland, D. J. Leturcq, A. M. Moriarty, P. S. Tobias, E. R. Bleeker, S. E. Goldblum, and J. D. Hasday. 1996. Asthma and endotoxin: lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 270:L736-L744.
35. 35. Ramadori, G., K.-H. Meyer zum Buschenfelde, P. S. Tobias, J. C. Mathison, and R. J. Ulevitch. 1990. Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes. Pathobiology 58:89-94.
36. 36. Grube, B. J., C. G. Cochane, R. D. Ye, C. E. Green, M. E. McPhail, R. J. Ulevitch, and P. S. Tobias. 1994. Lipopolysaccharide binding protein expression in primary human hepatocytes and HepG2 hepatoma cells. J. Biol. Chem. 269:8477-8482.
37. 37. Wan, Y., P. D. Freeswick, L. S. Khemlani, P. H. Kispert, S. C. Wang, G. L. Su, and T. R. Billiar. 1995. Role of lipopolysaccharide (LPS), interleukin-1, interleukin-6, tumor necrosis factor, and dexamethasone in regulation of LPS-binding protein expression in normal hepatocytes and hepatocytes from LPS-treated rats. Infect. Immun. 63:2435-2442.
38. 38. Schumann, R. R., C. J. Kirschning, A. Unebehaun, H. Aberle, H. P. Knopf, N. Lamping, R. J. Ulevitch, and F. Herrmann. 1996. The lipopolysaccharide-binding protein is a secretory class I acute-phase protein whose gene is transcriptionally activated by aprf/stat/3 and other cytokine-inducible nuclear proteins. Mol. Cell Biol. 16:3490-3503.
39. 39. Su, G. L., P. D. Freeswick, D. A. Geller, Q. Wang, R. A. Shapiro, Y. H. Wan, T. R. Billiar, D. J. Tweardy, R. L. Simmons, and S. C. Wang. 1994. Molecular cloning, characterization, and tissue distribution of rat lipopolysaccharide binding protein: evidence for extrahepatic expression. J. Immunol. 153:743-752.
40. 40. Wong, H. R., B. R. Pitt, G. L. Su, D. P. Rossignol, A. R. Steve, T. R. Billiar, and S. C. Wang. 1995. Induction of lipopolysaccharide-binding protein gene expression in cultured rat pulmonary artery smooth muscle cells by interleukin 1 beta. Am. J. Respir. Cell Mol. Biol. 12:449-454.
41. 41. Dentener, M. D., A. C. E. Vreugdenhil, P. H. M. Hoet, J. H. J. Vernooy, F. H. M. Nieman, D. Heumann, Y. M. W. Janssen, W. A. Buurman, and E. F. M. Wouters. 2000. Production of the acute phase protein LPS binding protein (LBP) by respiratory Type II epithelial cells: implications for local defense to bacterial endotoxins. Am. J. Respir. Cell Mol. Biol. 23:146-153.
42. 42. Goodman, R. B., R. M. Strieter, K. P. Steinberg, J. A. Milberg, D. P. Martin, R. J. Maunder, S. L. Kunkel, A. Walz, L. D. Hudson, and T. R. Martin. 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154:602-611.
43. 43. Pugin, J., B. Ricou, K. P. Steinberg, P. M. Suter, and T. R. Martin. 1996. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1β. Am. J. Respir. Crit. Care Med. 153:1850-1856.
44. 44. Martin, T. R. 1999. Lung cytokines and ARDS: Roger S. Mitchell Lecture. Chest 116:2S-8S.
45. 45. Hasday, J. D., W. Dubin, S. Mongovin, S. E. Goldblum, P. Swoveland, D. J. Leturcq, A. M. Moriarty, E. R. Bleeker, and T. R. Martin. 1997. Bronchoalvelar macrophage CD14 expression: shift between the membrane-associated and soluble pools. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 272: L925-L933.
46. 46. Fearns, C., V. V. Kravchenko, R. J. Ulevitch, and D. J. Loskutoff. 1995. Murine CD14 gene expression in vivo: extramyeloid synthesis and regulation by lipopolysaccharide. J. Exp. Med. 181:857-866.
47. 47. Fearns, C., and R. J. Ulevitch. 1998. Effect of recombinant interleukin-1beta on murine CD14 gene expression in vivo. Shock 9:157-163.
48. 48. Kalina, M., H. Blau, S. Riklis, and V. Kravtsov. 1995. Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 12:L144-L151.
49. 49. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler III, L. D. Hudson, R. J. Maunder, C. Crim, and T. M. Hyers. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1976-1981.
50. 50. Greene, K. E., J. R. Wright, K. P. Steinberg, J. T. Ruanski, E. Caldwell, W. B. Wong, W. Hull, J. A. Whitsett, T. Akino, Y. Kuroki, et al. 1999. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am. J. Respir. Crit. Care Med. 160:1843-1850.
51. 51. Schimke, J., J. Mathison, J. Morgiewicz, and R. J. Ulevitch. 1998. AntiCD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc. Natl. Acad. Sci. USA 95:13875-13880.
52. 52. Leturcq, D. J., A. M. Moriarty, G. Talbott, R. K. Winn, T. R. Martin, and R. J. Ulevitch. 1996. Antibodies against CD14 protect primates from endotoxin-induced shock. J. Clin. Invest. 98:1533-1538.
53. 53. Frevert, C. W., G. Matute-Bello, S. J. Skerrett, R. B. Goodman, O. Kajikawa, T. Stittipunt, and T. R. Martin. 2000. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J. Immunol. 164:5439-5445.